Flovent Inhaler

- Pulmonary Sequelae at Six Months following Extracorporeal Membrane Oxygenation (3)

Pulmonary Sequelae at Six Months following Extracorporeal Membrane Oxygenation (3)The decision regarding whether or not an infant required supplemental oxygen was based on arterial blood gas values, correlated with a tc02 measurement, obtained prior to discharge from the NICU. This allowed us to detect any drop in Pa02 during arterial puncture. Supplemental oxygen was continued if the Pa02 was less than 70 mm Hg while the infant was breathing room air at rest. Pulmonary medications were prescribed by the primary pediatrician assigned to follow the patient based on clinical assessment. This decision was made independent of the research studies performed.
Pulmonary mechanics and gas exchange were studied at 6 months of corrected age. Informed consents were obtained from the parents prior to study. The study was approved by the Committee on Clinical Investigations (institutional review board) of Childrens Hospital of Los Angeles.
Oxygenation was studied by continuous noninvasive monitoring for 1 to 2 h to include periods of feeding, wakefulness and sleep during a nap after feeding. No sedative medication was used to induce sleep for this part of the assessment. Arterial oxygen saturation by pulse oximetry (Nellcor 200, Hayward CA), the pulse signal from the pulse oximeter, tc02 and PaC02 (Sensormedics Transend Cutaneous Gas System with electrode heated to 44°C, SensorMedics), ECG, heart rate and respirations by chest wall impedance and electrooculogram were continuously recorded on a Gould 16-channel recorder.

August 1, 2013 Pulmonary function
Tags: chronic lung disease mechanical ventilation neonatal respiratory failure pulmonary function respiratory failure